Cargando…

Dose optimization of cefotaxime as pre‐emptive treatment in critically ill adult patients: A population pharmacokinetic study

AIMS: To describe the pharmacokinetics (PK) of cefotaxime as pre‐emptive treatment in critically ill adult patients, including covariates and to determine the probability of target attainment (PTA) of different dosage regimens for Enterobacterales and Staphylococcus aureus . METHODS: Five samples we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roelofsen, Eveline E., Abdulla, Alan, Muller, Anouk E., Endeman, Henrik, Gommers, Diederik, Dijkstra, Annemieke, Hunfeld, Nicole G. M., de Winter, Brenda C. M., Koch, Birgit C. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087439/ https://www.ncbi.nlm.nih.gov/pubmed/35942921 http://dx.doi.org/10.1111/bcp.15487

Ejemplares similares

Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients
por: Abdulla, Alan, et al.
Publicado: (2020)

Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)
por: Abdulla, Alan, et al.
Publicado: (2020)

Health Care Costs of Target Attainment for Beta-Lactam Antibiotics in Critically Ill Patients: A Retrospective Analysis of the EXPAT Study
por: Ewoldt, Tim M. J., et al.
Publicado: (2022)

Pharmacokinetics of Haloperidol in Critically Ill Patients: Is There an Association with Inflammation?
por: Li, Letao, et al.
Publicado: (2022)

Meropenem Model-Informed Precision Dosing in the Treatment of Critically Ill Patients: Can We Use It?
por: Li, Letao, et al.
Publicado: (2023)

Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nationwide cross-sectional study
por: Ewoldt, Tim M. J., et al.
Publicado: (2022)

Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial
por: Ewoldt, Tim M. J., et al.
Publicado: (2022)

Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19
por: Smeets, Tim J. L., et al.
Publicado: (2022)

Plasma protein binding of ceftriaxone in critically ill patients: can we predict unbound fractions?
por: Ewoldt, Tim M J, et al.
Publicado: (2023)

Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis
por: Hartman, Stan J. F., et al.
Publicado: (2019)

Population pharmacokinetics of cefotaxime in intensive care patients
por: Swartling, Maria, et al.
Publicado: (2021)

Population pharmacokinetics of intravenous cefotaxime indicates that higher doses are required for critically ill children
por: Hartman, Stan J. F., et al.
Publicado: (2022)

Pharmacodynamics of Flucloxacillin in a Neutropenic Murine Thigh Infection Model: A Piece of the Puzzle towards Evidence-Based Dosing
por: Roelofsen, Eveline E., et al.
Publicado: (2022)

Reply to van den Berg and van der Hoeven: In Patients with ARDS, Optimal PEEP Should Not Be Determined Using the Intersection of Relative Collapse and Relative Overdistention
por: van der Zee, Philip, et al.
Publicado: (2020)

Electrical Impedance Tomography for Positive End-Expiratory Pressure Titration in COVID-19–related Acute Respiratory Distress Syndrome
por: van der Zee, Philip, et al.
Publicado: (2020)

PEEP-FiO(2) table versus EIT to titrate PEEP in mechanically ventilated patients with COVID-19-related ARDS
por: Somhorst, Peter, et al.
Publicado: (2022)

Reply to: Higher PEEP in intubated COVID-19-associated ARDS patients? We are not sure
por: Somhorst, Peter, et al.
Publicado: (2022)

Subcutaneous pharmacokinetics and dosage regimen of cefotaxime in buffalo calves (Bubalus bubalis)
por: Sharma, Suresh Kumar, et al.
Publicado: (2006)

Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
por: Guo, Tingjie, et al.
Publicado: (2022)

Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients
por: de Velde, Femke, et al.
Publicado: (2021)

A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality
por: van der Zee, Philip, et al.
Publicado: (2020)

CEFOTAXIME IN THE TREATMENT OF BACTERIAL MENINGITIS
por: Asmar, Basim I, et al.
Publicado: (1984)

Population pharmacokinetics of nadroparin for thromboprophylaxis in COVID‐19 intensive care unit patients
por: Romano, Lorenzo G. R., et al.
Publicado: (2022)

The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial
por: Abdulla, A., et al.
Publicado: (2020)

Progressive respiratory failure in COVID-19: a hypothesis
por: Endeman, Henrik, et al.
Publicado: (2020)

vvECMO can be avoided by a transpulmonary pressure guided open lung concept in patients with severe ARDS
por: van der Zee, Philip, et al.
Publicado: (2019)

Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation
por: Shang, Zhen-Hai, et al.
Publicado: (2022)

Optimal dosing of cefotaxime and desacetylcefotaxime for critically ill paediatric patients. Can we use microsampling?
por: Guerra Valero, Yarmarly C, et al.
Publicado: (2022)

Efficacy and pharmacokinetics of intravenous paracetamol in the critically ill patient
por: Samson, AD, et al.
Publicado: (2009)

Effect of Methylprednisolone on Inflammation and Coagulation in Patients with Severe COVID-19: A Retrospective Cohort Study
por: Tromp, Katja, et al.
Publicado: (2021)

The rapid detection of cefotaxime-resistant Enterobacteriaceae by HPLC
por: Robinson, Andrew M, et al.
Publicado: (2016)

Soluble urokinase plasminogen activator receptor and procalcitonin for risk stratification in patients with a suspected infection in the emergency department: a prospective cohort study
por: Tong-Minh, Kirby, et al.
Publicado: (2023)

Pharmacokinetics of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Terminally Ill Adult Patients
por: Franken, Linda G., et al.
Publicado: (2015)

Evaluation of hypercalciuria in patients receiving intravenous Cefotaxime
por: Kalantari, Zahra, et al.
Publicado: (2019)

Review of Scavenged Sampling for Sustainable Therapeutic Drug Monitoring: Do More With Less
por: Schouwenburg, Stef, et al.
Publicado: (2022)

No Resistance to Penicillin, Cefuroxime, Cefotaxime, or Vancomycin in Pneumococcal Pneumonia
por: Yayan, Josef, et al.
Publicado: (2015)

Identification and Characterization of Cefotaxime Resistant Bacteria in Beef Cattle
por: Mir, Raies A., et al.
Publicado: (2016)

Predicting mortality in adult patients with sepsis in the emergency department by using combinations of biomarkers and clinical scoring systems: a systematic review
por: Tong-Minh, Kirby, et al.
Publicado: (2021)

Management and outcome of critically ill pregnant women with COVID-19
por: van Genderen, Michel E., et al.
Publicado: (2022)

High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department
por: Tong-Minh, Kirby, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_34mr2e021vb27dqfmk59dfk6ds